FDA Panel Casts SSRIs During Pregnancy as Risky—Many Experts Disagree

This Medical News article discusses claims about antidepressant treatment during pregnancy presented at a recent panel organized by the US Food and Drug Administration.

Authors

Institutions

Publication Details

Journal
JAMA
Published
2025-08-15
DOI
https://doi.org/10.1001/jama.2025.14105
Citations
2
Primary Topic
Birth, Development, and Health
Type
article
Field-Weighted Citation Impact
6.99
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

FDA Panel Casts SSRIs During Pregnancy as Risky—Many Experts Disagree

Lars Schneider
2 citations
JAMA
Birth, Development, and Health
6.99
article

FDA Panel Casts SSRIs During Pregnancy as Risky—Many Experts Disagree

Lars Schneider
article en
2 citations

Abstract

This Medical News article discusses claims about antidepressant treatment during pregnancy presented at a recent panel organized by the US Food and Drug Administration.

JAMAVol. 334(11)
Art Institute of New York (US)
Good health and well-being
Openalex Percentile: Top 4%
Birth, Development, and Health
6.99
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

FDA Panel Casts SSRIs During Pregnancy as Risky—Many Experts Disagree — Lars Schneider · JAMA (2025) | TGRS Research Map | TGRS